Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Affamed Therapeutics, Antengene, Asieris Pharmaceuticals, Astrazeneca, Caliway Biopharmaceuticals, Iveric Bio, Recce Pharmaceuticals.